Supplementary Table S3 from Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma Other uri icon

  •  
  • Overview
  •  
  • Identity
  •  
  • View All
  •  

abstract

  • <p>Supplementary Table S3. SLITRK6 Expression Levels, H-Score: Parts A, B, and C, Expansion Phase (FAS)</p>

authors

  • Petrylak, Daniel P
  • Eigl, Bernhard J
  • George, Saby
  • Heath, Elisabeth I
  • Hotte, Sebastien
  • Chism, David D
  • Nabell, Lisle M
  • Picus, Joel
  • Cheng, Susanna Y
  • Appleman, Leonard J
  • Sonpavde, Guru P
  • Morgans, Alicia K
  • Pourhosseini, Pourya
  • Wu, Ruishan
  • Standley, Laura
  • Croitoru, Ruslan
  • Yu, Evan Y

publication date

  • January 5, 2024